A subscription to JoVE is required to view this content. Sign in or start your free trial.
This protocol details the isolation of live immune and non-immune populations from the mouse lung at a steady state and following influenza infection. It also provides gating strategies for identifying epithelial and myeloid cell subsets.
The lung is continuously exposed to pathogens and other noxious environmental stimuli, rendering it vulnerable to damage, dysfunction, and the development of disease. Studies utilizing mouse models of respiratory infection, allergy, fibrosis, and cancer have been critical to reveal mechanisms of disease progression and identify therapeutic targets. However, most studies focused on the mouse lung prioritize the isolation of either immune cells or epithelial cells, rather than both populations concurrently. Here, we describe a method for preparing a comprehensive single-cell suspension of both immune and non-immune populations suitable for flow cytometry and fluorescence-activated cell sorting. These populations include epithelial cells, endothelial cells, fibroblasts, and a variety of myeloid cell subsets. This protocol entails bronchoalveolar lavage and subsequent inflation of the lungs with dispase. Lungs are then digested in a liberase mixture. This method of processing liberates a variety of diverse cell types and results in a single-cell suspension that does not require manual dissociation against a filter, promoting cell survival and yielding high numbers of live cells for downstream analyses. In this protocol, we also define gating schemes for epithelial and myeloid cell subsets in both naïve and influenza-infected lungs. Simultaneous isolation of live immune and non-immune cells is key for interrogating intercellular crosstalk and gaining a deeper understanding of lung biology in health and disease.
The lung is composed of the airways, alveoli, and interstitium. Immune and non-immune cells reside within these compartments to contribute to both homeostatic lung function (gas exchange) and host defense against environmental insults, such as viral infection. The large and small airways, or the bronchi and bronchioles, are lined by epithelial cells. The predominant epithelial cells in these regions are club and ciliated cells which are responsible for secreting protective molecules and facilitating mucociliary clearance1. The alveoli are the most distal structures in the lung, lined by two epithelial cell types, alveolar type I cells (ATIs) an....
This protocol complies with the guidelines of the Institutional Animal Care and Use Committee at Harvard Medical School (Grant numbers: R35GM150816 and P30DK043351). Female C57BL/6J mice aged 8-12 weeks were used for the experiments. This protocol is also suitable for male mice. The details of the reagents and equipment used in this study are provided in the Table of Materials.
1. Preparation of materials
A successful digest will result in approximately 20-25 million cells with 90%-95% viability. If approximately 25,000 counting beads are added to an 8% fraction of the lung, beads should compromise 1%-3% of collected events. After gating on singlets, approximately 90%-95% of cells should be Zombie Aqua negative (indicating viability) (Figure 2A, Figure 3A).
Of CD45+ cells, CD64+F4/80+ cells are defined .......
This protocol outlines a mouse lung digest that isolates approximately 20-25 million cells per mouse with 90%-95% viability. It additionally allows for the collection of BALF for further analysis. The resultant cell suspension is compatible with multiple laboratory techniques, including flow cytometry and fluorescence-activated cell sorting to isolate cells for sequencing or cell culture. Briefly, after perfusion, BALF is collected, and lungs are inflated with dispase. Lungs are then chopped and digested in a liberase/DN.......
The authors have nothing to disclose.
This work was supported in part by grants from the National Institutes of Health (R35GM150816 and P30DK043351), Charles H. Hood Foundation, and Harvard Stem Cell Institute. We thank Alexander Mann and all other members of the Franklin laboratory for their help and advice in designing and refining the flow cytometry gating schemes and analyses. We also thank the Immunology Flow Cytometry Core at Harvard Medical School. Flow cytometry analysis was performed using FlowJo. Figure schematics were created using BioRender.
....Name | Company | Catalog Number | Comments |
1 mL syringe with Slip Tip | VWR | BD309659 | |
1.7 mL microcentrifuge tube | DOT Scientific | RN1700-GMT | |
10 mL pipettes (disposable) | Fisher Scientific | 12-567-603 | |
10 mL Syringe with BD Luer-Lok Tip | VWR | 75846-756 | |
123 count eBeads Counting Beads | Thermo Scientific | 01-1234-42 | |
12-channel pipette (30-300ul) | USA Scientific | 7112-3300 | |
16% paraformaldehyde | VWR | 100503-917 | |
23 G needle with regular bevel | VWR | 305194 | |
27 G needle with regular bevel | VWR | BD305109 | |
5 mL pipettes (disposable) | Thermo Fisher Scientific | 170373 | |
50 mL centrifuge tubes | Olympus | 28-108 | |
96-well round bottom plate | Corning | 3797 | |
ACK lysing buffer | Gibco | A100492-01 | |
Alexa Fluor 488 anti-mouse CD11c | BioLegend | 117311 | |
Anti-F4/80 Rat Monoclonal Antibody (PE (Phycoerythrin)/Cy7) | BioLegend | 123114 | |
APC anti-mouse CD64 (FcγRI) | BioLegend | 139306 | |
APC/Cyanine7 anti-mouse CD45 | BioLegend | 103115 | |
BD Insyte Autoguard Shielded IV Catheters | VWR | 381423 | |
Brilliant Violet 421 anti-mouse I-A/I-E (MHC-II) | BioLegend | 107632 | |
Brilliant Violet 421 anti-mouse/human CD11b | BioLegend | 101235 | |
Brilliant Violet 605 anti-mouse Ly-6C | BioLegend | 128036 | |
Brilliant Violet 711 anti-mouse CD45 | BioLegend | 103147 | |
C57BL/6J mice | Jackson Laboratories | ||
Cd140a (PDGFRA) Monoclonal Antibody (APA5), PE-Cyanine7, eBioscience | Life Technologies | 25-1401-82 | |
CD170 (Siglec F) Monoclonal Antibody (1RNM44N), PE | Life Technologies | 12170280 | |
Cell strainers | Corning | 352350 | |
Centrifuge | Eppenodorf | Centrifuge 5910R | |
Deoxyribonuclease I from bovine pancreas (DNase) | Millipore Sigma | DN25-100MG | Reconstituted at 20 mg/mL in DPBS as stock solution stored at -20 °C |
Dispase | VWR | 76176-668 | Thawed once and stored as 1mL aliquots at -20 °C |
Dissection forceps (Dumont #7) | Fine Science Tools | 11297-00 | |
Dissection scissors | Fine Science Tools | 14060-09 | |
DPBS | Thermo Fisher Scientific | 14190250 | |
eBioscience fixation kit | Life Technologies | 00-5523-00 | |
EDTA | Life Technologies | AM9260G | |
Ethanol | VWR | TX89125170HU | |
FBS | GeminiBio | 100-106 | Thawed once and heat-inactivated before long-term storage as aliquots at -20 °C |
FITC anti-mouse CD31 Antibody | BioLegend | 102406 | |
Gibco RPMI 1640 Medium | Fisher Scientific | 11-875-093 | |
Glass slides | Fisher Scientific | 12-552-3 | |
graduated reservoir | USA Scientific | 1930-2235 | |
Ice bucket | Corning | 432128 | |
Ketamine hydrocholoride injection (100 mg/mL) | Dechra | Ketamine and xyalazine euthanization mixture can be kept at 30 mg/mL ketamine hydrochloride and 4.5mg/mL xylazine in sterile DPBS for up to one month. | |
Liberase | Millipore Sigma | 5401119001 | Reconstituted at 5 mg/mL in DPBS as stock solution stored at -20 °C |
Lids for 96-well plates | Fisher Scientific | 07-201-731 | |
Orbital Incubator Shaker | Barnstead Lab-Line | SHKE4000 | |
p1000 pipette | Eppenodorf | 3123000063 | |
p1000 tips | USA Scientific | 1122-1830 | |
p200 pipette | Eppenodorf | 3123000055 | |
p200 tips | USA Scientific | 1110-1700 | |
PE anti-mouse CD326 (Ep-CAM) | BioLegend | 118206 | |
PerCP/Cyanine5.5 anti-mouse CD104 Antibody | BioLegend | 123614 | |
PerCP/Cyanine5.5 anti-mouse Ly-6G | BioLegend | 127616 | |
Pipet-Aid | Drummond | 4-000-101 | |
Purified anti-mouse CD16/32 | BioLegend | 101302 | Referred to as "Fc block" in text |
Spray bottle | VWR | 23609-182 | |
Suture (Size 2-0) | VWR | 100190-026 | |
Underpads | VWR | 56617-014 | |
Xysed (xylazine 100mg/mL) | Pivetal | See ketamine hydrocholoride notes above. | |
Zombie Aqua Fixable Viability Kit | BioLegend | 423102 |
Request permission to reuse the text or figures of this JoVE article
Request PermissionExplore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2025 MyJoVE Corporation. All rights reserved